Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Xencor Inc chart...

About the Company

We do not have any company description for Xencor Inc at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

301

Exchange

Nasdaq

$421M

Total Revenue

301

Employees

$1B

Market Capitalization

-9.23

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $XNCR News

Analyst Scoreboard: 6 Ratings For Xencor

9d ago, source:

In the preceding three months, 6 analysts have released ratings for Xencor (NASDAQ:XNCR), presenting a wide array of ...

Xencor Inc XNCR

10d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Xencor Appoints Bart Cornelissen as Chief Financial Officer

16d ago, source: Stockhouse

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart ...

Xencor Appoints Bart Cornelissen As CFO

16d ago, source: Business Insider

(RTTNews) - Xencor, Inc. (XNCR), focused on cancer and other serious diseases, on Tuesday announced that it has appointed Bart Cornelissen as chief financial officer. On October 26, 2023 ...

Xencor: Q4 Earnings Snapshot

1mon ago, source: The News-Times

PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Tuesday reported a loss of $19.1 million in its fourth quarter. The Pasadena, California-based company said it had a loss ...

Xencor, Inc. Common Stock (XNCR)

1mon ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Xencor Appoints Bart Cornelissen as Chief Financial Officer

16d ago, source: Yahoo Finance

PASADENA, Calif., April 09, 2024--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other ...

Xencor Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...